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Abstract
Human mitochondrial protein mitoNEET is a novel target of type II diabetes drug pioglitazone,
and contains a redox active [2Fe–2S] cluster that is hosted by a unique ligand arrangement of three
cysteine and one histidine residues. Here we report that zinc ion can compete for the [2Fe–2S]
cluster binding site in human mitoNEET and potentially modulate the physiological function of
mitoNEET. When recombinant mitoNEET is expressed in Escherichia coli cells grown in M9
minimal media, purified mitoNEET contains very little or no iron–sulfur clusters. Addition of
exogenous iron or zinc ion in the media produces mitoNEET bound with a [2Fe–2S] cluster or
zinc, respectively. Mutations of the amino acid residues that hosting the [2Fe–2S] cluster in
mitoNEET diminish the zinc binding activity, indicating that zinc ion and the [2Fe–2S] cluster
may share the same binding site in mitoNEET. Finally, excess zinc ion effectively inhibits the
[2Fe–2S] cluster assembly in mitoNEET in E. coli cells, suggesting that zinc ion may impede the
function of mitoNEET by blocking the [2Fe–2S] cluster assembly in the protein.
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Human mitochondrial protein mitoNEET is a novel target of type II diabetes drug
pioglitazone (Colca et al. 2004). The protein is localized on mitochondrial outer membrane
(Wiley et al. 2007a) and belongs to a small protein family that contains a conserved CDGSH
domain (Lin et al. 2011). In addition to pioglitazone, mitoNEET also binds natural
compounds NADPH (Zhou et al. 2010) and resveratrol-3-sulfate (Arif et al. 2011), although
their physiological significance remains elusive. Expression of soluble C-terminal
mitoNEET (residue 33–108) in Escherichia coli cells grown in Luria–Bertani (LB) media
produced a protein that contains a [2Fe–2S] cluster (Wiley et al. 2007b). Crystallographic
studies revealed that mitoNEET forms a homodimer with each monomer hosting a [2Fe–2S]
cluster via three cysteine (Cys-72 and Cys-74 and Cys-83) and one histidine (His-87)
residues (Hou et al. 2007; Lin et al. 2007; Paddock et al. 2007). The [2Fe–2S] cluster in
mitoNEET is redox active (Tirrell et al. 2009) with a midpoint redox potential of ~0 mV (pH
6.0) (Bak et al. 2009). The redox property of the [2Fe–2S] cluster in mitoNEET can be
further modulated by pH (Tirrell et al. 2009), NADP+/NADPH (Zhou et al. 2010; Zuris et al.
2012), the diabetes drug pioglitazone (Bak et al. 2009), and the inter-domain communication
within mitoNEET (Baxter et al. 2011). Deletion of mitoNEET in mice resulted in a reduced
oxidative phosphorylation capacity in mitochondria (Wiley et al. 2007a), suggesting that
mitoNEET has a crucial role for energy metabolism. While the physiological function of
mitoNEET has not been fully established, it has recently been postulated that mitoNEET
may be involved in iron– sulfur cluster biogenesis by transferring the assembled clusters to
target proteins (Zuris et al. 2011, 2012).
The conserved CDGSH domain which is part of the [2Fe–2S] cluster binding site in
mitoNEET (Hou et al. 2007; Lin et al. 2007; Paddock et al. 2007) was initially annotated as
a zinc-finger motif (Wiley et al. 2007a), although the potential zinc binding activity of
mitoNEET was not investigated. Zinc is the second most abundant transition metal in the
human body, and has an important role in facilitating the correct folding of proteins,
stabilizing the domain structure, and providing catalytic functions in various enzymes
(Beyersmann and Haase 2001). On the other hand, excess zinc in cells has been linked to
several human diseases (Koh et al. 1996; Cuajungco and Lees 1997; Duce et al. 2010).
Whereas the molecular mechanism for zinc-mediated cytotoxicity has not been fully
understood, increasing evidence indicated that excess zinc can disrupt energy metabolism
and ATP production in mitochondria (Sharpley and Hirst 2006; Lemire et al. 2008). Since
zinc and iron–sulfur cluster share the same binding site in proteins such as the iron– sulfur
cluster assembly protein IscU (Ramelot et al. 2004; Liu et al. 2005) and in the CysB motif of
the eukaryotic DNA polymerase C-terminal domain (Klinge et al. 2009; Netz et al. 2012),
mis-incorporation of zinc ion into the iron–sulfur cluster binding sites could result in
dysfunctional protein and contribute to the metal-mediated cytotoxicity (Pagani et al. 2007).
Here, we report that human mitoNEET is able to bind zinc ion likely within the [2Fe–2S]
cluster binding site, and that excess zinc can effectively block the [2Fe–2S] cluster assembly
in mitoNEET in E. coli cells. The results suggest that zinc ion may impede the energy
metabolism in mitochondria by disrupting the [2Fe–2S] cluster assembly in mitoNEET.
Materials and methods
Protein purification
The cDNA encoding human mitoNEET33–108 was cloned from cDNA library. The PCR
product was digested with restriction enzymes NcoI and HindIII and ligated to an expression
vector pET28b+ (Novagen Co). The cloned DNA fragment was confirmed by direct
sequencing, and recombinant mitoNEET was expressed in E. coli BL21 strain grown in
either rich LB media or M9 minimal media supplemented with glycerol (0.2 %), thiamin (5
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µg ml−1) and 20 amino acids (each at 10 µg ml−1). After 4 h of incubation at 37 °C with
aeration (250 rpm), ferric citrate or ZnSO4 was added 10 min before the protein expression
was induced with isopropyl β-D-1-thiogalactopyranoside (200 µM) under aerobic
conditions. The cells were then grown at room temperature with aeration (150 rpm)
overnight before being harvested. The mitoNEET mutants in which cysteine residues were
substituted with serine were constructed using the QuikChange site-directed mutagenesis kit
(Stratagene Co.). The growth media and all chemicals were prepared with double-distilled
de-ionized water. Proteins were purified following the procedures described in Yang et al.
(2006), and purity of purified protein was over 95 %, judging from the SDS/PAGE followed
by the Coomassie blue staining. The protein concentration of purified mitoNEET was
measured at 280 nm using an extinction coefficient of 8.6 cm−1 mM−1.
Iron–sulfur cluster assembly in IscU
Escherichia coli apo-IscU was purified from E. coli cells grown in M9 minimal media
without any addition of exogenous metal ions as described previously (Wang et al. 2010).
For the iron–sulfur cluster assembly reaction, purified apo-IscU was incubated with cysteine
desulfurase IscS (0.5 µM), NaCl (200 mM), Tris (20 mM, pH 8.0), and Fe(NH4)2 (SO4)2
(100 µM) in the presence of dithiothreitol (2 mM) under anaerobic conditions (Yang et al.
2006). L-Cysteine (1 mM) was then added to initiate the iron– sulfur cluster assembly in
IscU. The iron–sulfur cluster assembly in IscU was monitored in a Beckman DU-640 UV–
visible spectrometer equipped with a temperature controller.
EPR measurements
The X-band EPR (Electron paramagnetic resonance) spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power,
10.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 25
K; receive gain, 105.
Metal content analyses
The iron content in protein samples was determined using an iron indicator ferroZine
following the procedures described in (Cowart et al. 1993). The zinc contents in protein
samples were determined using a zinc indicator PAR (4-(2-pyridylazo)-resorcinol) (Bae et
al. 2004). The zinc and iron contents in protein samples were also analyzed by the
Inductively Coupled Plasma-Emission Spectrometry (ICP-ES). Both methods provided
similar results.
Results
Human mitoNEET binds zinc in E. coli cells grown in M9 minimal media
When recombinant human mitoNEET was expressed in E. coli cells grown in LB media,
purified protein had absorption peaks at 330, 458 and 530 nm, indicative of a [2Fe–2S]
cluster, as reported previously (Wiley et al. 2007b). However, when recombinant mitoNEET
was expressed in E. coli cells grown in M9 minimal media, purified mitoNEET had very
little or no absorption of iron–sulfur clusters (Fig. 1a). The electron paramagnetic resonance
(EPR) measurements confirmed that while mitoNEET purified fromE. coli cells grown in
LB media contained a [2Fe–2S] cluster, mitoNEET purified from E. coli cells grown in M9
minimal media had no detectable amounts of iron–sulfur clusters (Fig. 1b).
When the M9 minimal media were supplemented with exogenous iron before expression of
mitoNEET was induced in E. coli cells, purified mitoNEET had absorption peaks at 330,
458 and 530 nm of the [2Fe–2S] cluster (Fig. 2a), indicating that supplement of exogenous
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iron can restore the [2Fe–2S] cluster assembly in mitoNEET in cells. In parallel, when the
M9 minimal media were supplemented with exogenous zinc before expression of mitoNEET
was induced in E. coli cells, purified mitoNEET had no absorption peaks of iron– sulfur
clusters (Fig. 2a). However, the metal content analyses showed that mitoNEET purified
from E. coli cells grown in M9 minimal media supplemented with zinc contained about 0.49
± 0.05 zinc atom per protein monomer (Fig. 2b) (n = 3), suggesting that human mitoNEET
is able to bind zinc in E. coli cells.
Zinc and the [2Fe–2S] cluster likely share the binding site in mitoNEET
The putative zinc-finger motif CDGSH in mitoNEET contains two amino acid residues
(Cys-83 and His-87) that are the ligands for the [2Fe–2S] cluster (Hou et al. 2007; Lin et al.
2007; Paddock et al. 2007). To test whether the amino acid residues that host the [2Fe–2S]
cluster in mitoNEET are involved in zinc binding, we constructed mitoNEET mutants in
which each of the residues (Cys-72, Cys-74, Cys-83, and His-87) was replaced with serine.
When the mitoNEET mutant proteins were expressed in E. coli cells grown in the M9
minimal media supplemented with ferric citrate, none of the mutant proteins were able to
assemble an intact [2Fe–2S] cluster (Fig. 3a). In parallel, when the mitoNEET mutant
proteins were expressed in E. coli cells grown in the M9 minimal media supplemented with
ZnSO4, purified mitoNEET mutant proteins contained less than half of total zinc bound in
wild type mitoNEET (Fig. 3b). These results suggested that zinc and [2Fe–2S] cluster likely
share the same binding site in mitoNEET.
Zinc competes for the [2Fe–2S] cluster binding site in mitoNEET in E. coli cells
If mitoNEET can bind zinc and [2Fe–2S] cluster in the same binding site, we would
anticipate that excess zinc ion may compete for the [2Fe–2S] cluster binding in mitoNEET.
To test this idea, mitoNEET was expressed in E. coli cells grown in the M9 minimal media
supplemented with various amounts of zinc and iron ions. Figure 4a shows an example of
competition between zinc and iron–sulfur cluster binding in mitoNEET in E. coli cells.
When M9 minimal media were supplemented with ferric citrate, purified mitoNEET
contained a [2Fe–2S] cluster as expected (Fig. 4a). Addition of excess zinc ion (100 µM) to
the above M9 minimal media essentially eliminated the [2Fe–2S] cluster assembly in
mitoNEET (Fig. 4a) with concomitant increase of zinc content in the protein (Fig. 4b). Thus,
excess zinc ion can effectively block the [2Fe–2S] cluster assembly in mitoNEET in E. coli
cells grown in M9 minimal media.
Zinc inhibits the iron–sulfur cluster assembly in IscU
Iron–sulfur clusters are assembled by a group of dedicated proteins that are highly conserved
from bacteria to humans (Zheng et al. 1998; Lill 2009). Among them, IscU acts as a key
scaffold protein that assembles transient iron–sulfur clusters (Agar et al. 2000) and transfers
the clusters to target proteins (Raulfs et al. 2008). Interestingly, IscU, like mitoNEET, has
been shown to bind zinc in the iron–sulfur cluster binding site (Ramelot et al. 2004; Liu et
al. 2005). Thus, zinc ion may block the iron–sulfur cluster assembly in mitoNEET by
inhibiting the initial iron– sulfur cluster formation in IscU in cells.
To test this idea, apo-form IscU was incubated with ferrous iron, L-cysteine, and cysteine
desulfurase IscS, in the presence of dithiothreitol under anaerobic conditions as described
previously (Yang et al. 2006). Figure 5a shows the typical iron–sulfur cluster assembly
process in IscU under the experimental conditions. The absorption peak at 456 nm reflecting
the [2Fe–2S] cluster formation in IscU (Agar et al. 2000) quickly appeared upon addition of
L-cysteine and reached the maximum within 20 min. In contrast, when an equivalent amount
of zinc ion (relative to the iron concentration) was included in the incubation solution, the
iron–sulfur cluster assembly in IscU was greatly inhibited (Fig. 5b). As a control, addition of
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an equal amount of MgSO4 had no effect on the iron–sulfur cluster assembly in IscU under
the same experimental conditions (data not shown), suggesting that zinc ion has its specific
effect on the iron–sulfur cluster assembly in protein.
Discussion
Here we report that human outer mitochondrial membrane protein mitoNEET is able to bind
not only a [2Fe–2S] cluster but also zinc ion in E. coli cells. While recombinant human
mitoNEET expressed in E. coli cells grown in M9 minimal media contains very little or no
iron–sulfur clusters, addition of exogenous iron or zinc ion in M9 minimal media produces
mitoNEET bound with a [2Fe–2S] cluster or zinc, respectively. MitoNEET mutants that fail
to bind the [2Fe–2S] cluster also have a diminished binding activity for zinc, indicating that
zinc and iron–sulfur cluster may share the same binding site in mitoNEET. Finally, excess
zinc can effectively inhibit the [2Fe– 2S] cluster assembly in mitoNEET in E. coli cells.
Taken together, the results suggest that zinc may disrupt the physiological function of
mitoNEET by blocking the [2Fe–2S] cluster assembly in the protein.
It has previously been reported that zinc and iron– sulfur cluster share the same binding site
in some proteins including the iron–sulfur cluster assembly protein IscU (Ramelot et al.
2004; Liu et al. 2005) and the eukaryotic DNA polymerases (Klinge et al. 2009; Netz et al.
2012). Here we find that human mitochondrial protein mitoNEET can also bind zinc likely
within the iron–sulfur cluster binding site. Conceivably, there are other proteins with such a
flexible binding site to accommodate iron–sulfur cluster or zinc binding. It should be
emphasized that binding of iron–sulfur cluster or zinc ion in these proteins will depend on
intracellular concentrations of iron and zinc. In this context, at low concentrations, zinc may
regulate the activity of iron–sulfur proteins by competing for the iron–sulfur cluster binding
site. At high concentrations, zinc may become highly toxic by completely blocking the iron–
sulfur cluster assembly in proteins (Pagani et al. 2007).
While the physiological function of mitoNEET has not been fully established, it has recently
been postulated that mitoNEET may act as a carrier for iron–sulfur cluster assembly in
human cells (Zuris et al. 2011, 2012). Iron–sulfur clusters are involved in diverse cellular
functions, and assembly of iron–sulfur clusters requires a group of dedicated proteins that
are highly conserved from bacteria to humans (Zheng et al. 1998; Lill 2009). In bacteria,
iron–sulfur clusters are initially assembled in a scaffold protein IscU (Agar et al. 2000) and
transferred to target proteins (Raulfs et al. 2008). In eukaryotic cells, mitochondria are the
primary sites for initial iron–sulfur cluster assembly (Lill 2009). For iron–sulfur assembly in
cytosol and nucleus, the iron– sulfur clusters assembled in mitochondria may be transferred
across mitochondrial membranes (Lill 2009). MitoNEET, a mitochondrial outer membrane
protein, could be one of the missing components for transporting the assembled iron–sulfur
clusters from mitochondria to cytosol. Since deficiency of iron– sulfur clusters has been
attributed to a number of human diseases (Rouault and Tong 2008; Lill 2009), and
mitoNEET has an important role in energy metabolism (Wiley et al. 2007a), we propose that
excessive zinc may disrupt cellular functions by impeding iron–sulfur cluster assembly in
proteins such as mitoNEET in human cells.
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Metal occupancy of human mitoNEET expressed in E. coli cells depends on growth media.
Human mitoNEET was expressed in E. coli cells grown in LB media or M9 minimal media
under aerobic conditions. a UV–visible absorption spectra of purified mitoNEET. Purified
mitoNEET (75 µM) was dissolved in buffer containing Tris (20 mM, pH 8.0) and NaCl (200
mM). Insert is a photograph of SDS-PAGE gel of purified mitoNEET from E. coli cells
grown in LB (lane 1) or M9 minimal media (lane 2). b EPR spectra of purified mitoNEET.
MitoNEET (200 µM) purified from E. coli cells grown in LB (spectrum 1) or M9 minimal
media (spectrum 2) were dissolved in buffer containing Tris (20 mM, pH 8.0) and NaCl
(200 mM). Protein was reduced with freshly prepared sodium dithionite (1 mM) and
immediately frozen in liquid nitrogen until the EPR measurements
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Human mitoNEET binds zinc or a [2Fe–2S] cluster in E. coli cells. a UV–visible absorption
spectra of mitoNEET purified from E. coli cells grown in M9 minimal media supplemented
with no exogenous metal ions (spectrum 1), ZnSO4 (20 µM) (spectrum 2), or ferric citrate (5
µM) (spectrum 3). b iron, sulfide and zinc contents of mitoNEET purified from E. coli cells
grown in M9 minimal media supplemented with no exogenous metal ions (mitoNEET-apo-
form), ZnSO4 (20 µM) (mitoNEET-Zn), or ferric citrate (5 µM) (mitoNEET-Fe). The iron,
sulfide and zinc contents were presented as the ratio to mitoNEET monomer. The data are
averages plus standard deviations from three independent experiments
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Zinc and [2Fe–2S] cluster share the same binding site in mitoNEET. The mitoNEET
mutants (C72S, C74S, C83S and H87S) were expressed and purified from E. coli cells
grown in M9 minimal media supplemented with ferric citrate or ZnSO4. a UV–visible
absorption spectra of mitoNEET mutant proteins purified from E. coli cells grown in M9
minimal media supplemented with ferric citrate (5 µM). b The zinc content of mitoNEET
mutant proteins purified from E. coli cells grown in M9 minimal media supplemented with
ZnSO4 (20 µM). The ratio of zinc per mitoNEET monomer was plotted for wild type and
each mutant protein samples. The data are averages plus standard deviations from at least
three independent experiments
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Zinc competes for the [2Fe–2S] cluster binding site in mitoNEET in E. coli cells. a UV–
visible absorption spectra of mitoNEET purified from E. coli cells grown in M9 minimal
media supplemented with ferric citrate (2.0 µM) (spectrum 1), ferric citrate (2.0 µM) and
ZnSO4 (100 µM) (spectrum 2). The insert is a photograph of SDS/PAGE gel of purified
proteins. b Zinc and iron contents of mitoNEET purified from E. coli cells grown in M9
minimal media supplemented with ferric citrate (2.0 µM), or with ferric citrate (2.0 µM) and
ZnSO4 (100 µM). The data are representatives of three independent experiments
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Zinc inhibits the iron–sulfur cluster assembly in IscU in vitro. a Iron–sulfur cluster assembly
in IscU. Purified IscU (150 µM) was incubated with Fe(NH4)2(SO4)2 (100 µM), IscS (0.5
µM) and DTT (2 mM) under anaerobic conditions. L-cysteine (1 mM) was added after 5 min
pre-incubation at 37 °C. The UV–visible absorption spectrum was taken every 2 min for 24
min. b Same as (a) except 100 µM ZnSO4 was included in the incubation solution
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